Drug Approval | July 22, 2024
Rusan Pharma’s API plant in Ankleshwar receives USFDA GMP approval
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The facility is a part of Lupin Manufacturing Solutions
The Unit has been issued GMP Certification from ANVISA-Brazil
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Subscribe To Our Newsletter & Stay Updated
